176 related articles for article (PubMed ID: 34302367)
1. Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy.
Li P; Xue Y; Sun J; Chen M; Yu X; Zhao H; Gao Y; Zhang X; Jiang T; He J
Clin Cardiol; 2021 Oct; 44(10):1409-1415. PubMed ID: 34302367
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of alcohol septal ablation in mildly symptomatic or severely symptomatic patients with hypertrophic obstructive cardiomyopathy].
Sun JJ; Li PJ; Yu XP; Zhao H; Zhang XL; Tu CC; Zhang MD; Jiang TY; Song XT; He JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):513-520. PubMed ID: 37198123
[No Abstract] [Full Text] [Related]
3. [Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy].
Li PJ; Sun JJ; Chen ML; Yu XP; Zhao H; Gao YC; Zhang XL; Jiang TY; He JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):369-374. PubMed ID: 35399033
[No Abstract] [Full Text] [Related]
4. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
6. Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy.
Sun J; Liang L; Li P; Jiang T; Yu X; Ren C; Dong R; He J
Front Cardiovasc Med; 2022; 9():855491. PubMed ID: 35402524
[TBL] [Abstract][Full Text] [Related]
7. Gender Disparities in Clinical Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in the Chinese Han Population: A Cohort Study.
Wang Y; Zhao HW; Wang CF; Meng QK; Cui CS; Zhang XJ; Zhu Y; Fan CY; Luo DF; Chen BJ; Luan B; Hou AJ
Heart Lung Circ; 2020 Dec; 29(12):1856-1864. PubMed ID: 32611501
[TBL] [Abstract][Full Text] [Related]
8. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
9. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Cavigli L; Fumagalli C; Maurizi N; Rossi A; Arretini A; Targetti M; Passantino S; Girolami F; Tomberli B; Baldini K; Tomberli A; Antoniucci D; Yacoub MH; Marchionni N; Stefano PL; Cecchi F; Olivotto I
Int J Cardiol; 2018 Dec; 273():155-161. PubMed ID: 30213605
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
12. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.
Veselka J; Jensen MK; Liebregts M; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Tomasov P; Adlova R; Bundgaard H; Steggerda R; Ten Berg J; Faber L
Eur Heart J; 2016 May; 37(19):1517-23. PubMed ID: 26746632
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
15. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
Cooper RM; Shahzad A; McShane J; Stables RH
J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Survival After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Experience.
Fernandes V; Karimianpour A; Rier JD; Shaji S; Mullinax BJ; Wahlquist AH; Nielsen CD
J Invasive Cardiol; 2021 Oct; 33(10):E769-E776. PubMed ID: 34559674
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
